Get access

Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital

Authors

  • Emilia SAWICKI,

    1. Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
    2. Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands
    Search for more papers by this author
  • Kay STEWART,

    1. Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
    Search for more papers by this author
  • Swee WONG,

    1. Pharmacy Department, The Royal Women’s Hospital, Parkville
    Search for more papers by this author
  • Laura LEUNG,

    1. Pharmacy Department, The Royal Women’s Hospital, Parkville
    Search for more papers by this author
  • Eldho PAUL,

    1. Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Victoria, Australia
    Search for more papers by this author
  • Johnson GEORGE

    1. Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia
    Search for more papers by this author

Dr Johnson George, Centre for Medicine Use and Safety, Department of Pharmacy Practice, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, 381 Royal Parade, Parkville, VIC 3052, Australia. Email: Johnson.George@monash.edu

Abstract

Background:  Most women use medications at some stage in their pregnancy. Medication nonadherence during pregnancy could be detrimental to both mother and fetus.

Aims:  To study the extent and nature of the use of prescribed medications during pregnancy and factors associated with medication nonadherence.

Methods:  All women ≥18 years presenting for their 36th week antenatal visit at the pregnancy clinic of a maternity hospital were invited to complete an anonymous questionnaire that contained 61 items, including the Morisky scale. Factors associated with nonadherence were identified in univariate analysis; factors with P < 0.1 were further analysed in a binary logistic regression model.

Results:  The participants (n = 819) had a mean age of 30.8 ± 5.3 years. Most participants were born in Australia, lived with a partner, had university education, were nulliparous, carried one fetus and were nonsmokers. Of these participants, 322 (39.3%) reported a chronic health condition during pregnancy, the most common being asthma (104; 12.7%). Two hundred and seventeen (26.5%) were using prescribed medications, which included anti-anaemics (68; 8.3%), medicines for chronic airway conditions (64; 7.8%), vitamins and minerals (59; 7.2%) and anti-diabetics (43; 5.2%). Nonadherence was reported by 107 (59.1%) participants, mainly because of forgetting (79; 43.6%). Factors associated with nonadherence were having asthma (OR 0.26 (95% CI 0.095 – 0.72), P = 0.009) and using nonprescription dietary minerals (0.30 (0.10 – 0.87), P = 0.027).

Conclusions:  Adherence to prescribed medicines during pregnancy is alarmingly low. Health professionals should be more proactive in promoting adherence and assisting women avoid potential fetal harm because of nonadherence.

Ancillary